AcquisitionOther
PIERIS PHARMACEUTICALS, INC. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
PIERIS PHARMACEUTICALS, INC. -> target · $78.9 million
This transaction is the culmination of a comprehensive review of strategic alternatives, and our board of directors believes that the merger with Palvella is in the best interests of our stockholders.” Palvella ’ s QTORIN ™ Platform and QTORIN ™ rapamycin Palv
Open source record (SEC) ↗